查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1978943

支氣管內超音波切片檢查設備市場：按產品類型、產品系列、適應症、應用和最終用戶分類－2026-2032年全球市場預測

Endobronchial Ultrasound Biopsy Devices Market by Product Type, Product Offering, Indication, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，超音波切片檢查設備市場價值將達到 7.3874 億美元，到 2026 年將成長至 7.8505 億美元，到 2032 年將達到 12.0727 億美元，複合年成長率為 7.26%。

主要市場統計數據
基準年 2025 7.3874億美元
預計年份：2026年 7.8505億美元
預測年份 2032 12.0727億美元
複合年成長率 (%) 7.26%

對超音波切片檢查技術的臨床價值、技術基礎和影響其應用的策略因素進行了全面概述。

支氣管內超音波切片檢查設備將影像和組織取樣整合於單一操作流程中，已成為現代呼吸醫學中重要的診斷工具。這些設備結合了支氣管鏡檢查和超音波影像，提高了縱膈和周圍肺部病變定位和取樣的準確性。臨床醫生正在利用這項技術提高診斷準確性，減少重複治療，並支持腫瘤科、感染疾病和間質性肺病科等多個學科的決策。

新的技術進步和臨床工作流程的變革正在重新定義超音波切片檢查護理的準確性、安全性和操作整合性。

近年來，支氣管內超音波切片檢查設備領域發生了變革性的變化，這體現在影像解析度的提升、一次性耗材策略的改進以及複雜手術向門診的轉移。探頭設計和訊號處理的改進使得病灶和淋巴結的顯像更加清晰，從而能夠更精準地進行經支氣管針吸活體組織切片，並降低無法診斷檢體的比例。同時，製造商正優先研發一次性針頭套裝和保護鞘套，以簡化無菌操作流程並降低交叉感染的風險，這在後疫情時代的臨床管治中尤其重要。

美國關稅調整重組了供應鏈和籌資策略，增強了供應鏈的韌性，促進了整個醫療設備生態系統的供應商多元化和區域製造能力。

2025年美國關稅調整的累積影響已波及全球醫療設備供應鏈，迫使製造商和醫療服務提供者重新評估其超音波切片檢查設備的籌資策略。關稅導致進口零件成本上升，推高了製造成本，尤其是那些依賴跨境生產關鍵子組件和專用超音波換能器的公司。為因應這項挑戰，各公司加快了供應商多元化步伐，盡可能轉向本地供應商，並在某些情況下優先投資本地生產，以降低未來政策變化帶來的風險。

詳細的細分觀點揭示了產品類型、產品供應、最終用戶、應用和臨床適應症如何獨特地影響設備的選擇和實施。

從產品類型、產品線、終端用戶、應用和臨床適應症等角度對市場檢驗細分分析，可以清楚揭示市場績效促進因素和進入路徑。就產品類型而言，此領域可分為縱向探針和徑向探針。縱向探針可在引導下直接觀察縱膈和肺門淋巴結的穿刺活體組織切片，而徑向探針則擅長對周圍病變進行立體定位，從而實現互補的診斷策略。就產品而言，成像工作站和內視鏡系統等設備投資構成了資本規劃和綜合成本的基礎，而針組和保護鞘套等耗材則影響持續支出和手術能力。

美洲、歐洲、中東和非洲以及亞太地區的部署模式和商業性需求塑造了部署、培訓和售後市場策略。

區域趨勢正顯著影響著美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管預期和商業策略。在美洲，先進的三級醫療中心和強大的介入呼吸計畫集中分佈，推動了整合影像工作站和先進內視鏡系統的早期應用；與此同時，保險公司也日益關注手術流程，以確保成本效益和治療效果的一致性。手術向門診手術中心轉移，催生了新的採購重點，這些重點圍繞著設備的移動性、易用性和耗材生命週期管理。

競爭格局分析重點在於各種策略模式，從整合平台供應商到耗材專家，以及它們對採購和臨床部署的影響。

支氣管內超音波切片檢查領域的主要企業正在展現出廣泛的策略舉措，從平台整合產品到以耗材為中心的經營模式，不一而足。成熟的內視鏡製造商專注於系統層面的差異化，將高解析度成像工作站與模組化內視鏡架構相結合，以主導手術生態系統並促進耗材的輔助銷售。這些公司強調長期服務合約、臨床醫生培訓計劃以及捆綁式解決方案，以促進醫院整合並簡化採購談判。

為製造商和醫療保健提供者提供切實可行的、有影響力的策略行動，以增強臨床應用、供應鏈韌性和設備的長期價值。

產業領導者若想鞏固市場地位並支持永續的臨床應用，應採取一系列切實可行的策略，使創新與實際操作相契合。首先，應優先考慮內視鏡系統與成像工作站之間的端到端整合，以實現無縫的臨床工作流程，並減輕臨床醫生的工作負擔。引入全面的培訓課程和基於模擬的認證項目，可以加快技能提升，最大限度地減少切片檢查技術的差異，從而提高檢體品質和臨床醫生的信心。

採用穩健的混合方法研究途徑，結合專家訪談、臨床文獻綜述和基於三角測量的數據分析，以驗證檢驗並減少偏見。

本分析的調查方法結合了嚴謹的一手和二手調查方法，以確保分析的深度和有效性。一手資料收集包括對介入手術醫生、生物醫學工程師、檢體採集部門負責人和醫院管理人員進行結構化訪談，以了解他們在設備性能、培訓需求和耗材物流的真實經驗。這些專家意見體現在對臨床工作流程、設備人體工學和手術瓶頸的評估中。

整合策略重點，強調技術進步、供應鏈調整和協調的臨床策略，以最大限度地提高診斷效果。

總之，支氣管內超音波切片檢查設備在診斷準確性、手術安全性和操作效率方面佔據戰略地位。探頭設計、影像工作站和一次性耗材的技術創新正在提高診斷效能，同時也正在重塑門診手術中心、醫院和專科診所的手術操作方式。同時，關稅和報銷政策變化等外部壓力正迫使製造商和醫療機構重新思考其採購、定價和商業化模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：超音波切片檢查設備市場：依產品類型分類

  • 線性探頭
  • 徑向探針

第9章：超音波切片檢查設備市場（依產品類別分類）

  • 消耗品
    • 針具套裝
    • 保護鞘套
  • 裝置
    • 醫學影像工作站
    • 內視鏡系統

第10章：超音波切片檢查設備市場：依適應症分類

  • 癌症診斷
  • 感染疾病
  • 類肉瘤病

第11章：超音波切片檢查設備市場：依應用領域分類

  • 縱膈分期
  • 周邊性病變的診斷
  • 經支氣管針吸切片

第12章：超音波切片檢查設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章：超音波切片檢查設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：超音波切片檢查設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：超音波切片檢查設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國支氣管內超音波切片檢查設備市場

第17章：中國支氣管內超音波切片檢查設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ACE Medical Devices Pvt. Ltd.
  • Argon Medical Devices
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • EndoMed Systems GmbH
  • FUJIFILM Corporation
  • Huger Medical Instrument Co., Ltd.
  • Hunan Vathin Medical Instrument Co., Ltd.
  • Medi-Globe Technologies GmbH by DCC PLC
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Olympus Corporation
  • Siemens AG
  • STERYLAB Srl
  • TSK Laboratory International
  • Zamar Care
  • Zhuhai Pusen Medical Technology Co., Ltd.
Product Code: MRR-521BAA36EA81

The Endobronchial Ultrasound Biopsy Devices Market was valued at USD 738.74 million in 2025 and is projected to grow to USD 785.05 million in 2026, with a CAGR of 7.26%, reaching USD 1,207.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 738.74 million
Estimated Year [2026] USD 785.05 million
Forecast Year [2032] USD 1,207.27 million
CAGR (%) 7.26%

Comprehensive overview of clinical value, technological underpinnings, and strategic factors shaping adoption of endobronchial ultrasound biopsy technologies

Endobronchial ultrasound biopsy devices have emerged as a pivotal diagnostic modality within modern pulmonary care, bridging imaging and tissue acquisition in a single procedural workflow. These devices combine bronchoscopic access with real-time ultrasound visualization to improve localization and sampling of mediastinal and peripheral pulmonary lesions. Clinicians deploy the technology to enhance diagnostic yield, reduce repeat procedures, and support multidisciplinary decision-making across oncology, infectious disease, and interstitial lung disease programs.

Technologically, the field has matured from foundational ultrasound probes to integrated systems that emphasize ergonomics, imaging fidelity, and single-use consumables that lower cross-contamination risk. As procedural pathways evolve, payers and hospital systems increasingly evaluate not just device performance but also throughput, inventory complexity, and lifecycle costs. Consequently, procurement and clinical teams must consider device interoperability, training requirements, and post-market surveillance data when adopting or upgrading endobronchial ultrasound platforms.

This introduction frames the clinical value proposition, the convergence of imaging and biopsy capabilities, and the strategic considerations that healthcare organizations should weigh when assessing investment in endobronchial ultrasound biopsy technology. It sets the stage for subsequent analysis of technological shifts, regulatory influences, and supply chain factors that collectively shape adoption and clinical integration.

Emerging technological advancements and clinical workflow metamorphoses that are redefining precision, safety, and operational integration of endobronchial ultrasound biopsy care

Recent transformative shifts in the landscape of endobronchial ultrasound biopsy devices reflect advances in imaging resolution, single-use consumable strategies, and the migration of complex procedures into ambulatory settings. Improved probe design and signal processing have sharpened visualization of lesions and lymph nodes, enabling more precise transbronchial needle aspiration and reducing nondiagnostic samples. Simultaneously, manufacturers have prioritized disposable needle sets and protective sheaths that streamline sterilization workflows and mitigate cross-infection risks, which is particularly salient in post-pandemic clinical governance.

Concurrently, the evolution of integrated imaging workstations and scope systems has enhanced data capture, enabling smoother integration with electronic health records and procedural documentation. These developments support multidisciplinary tumor boards by delivering higher-fidelity images and biopsy metadata for longitudinal care decisions. In addition, the diffusion of the technology into ambulatory surgical centers and specialty clinics reflects procedural reimbursement shifts and efforts to improve patient throughput while containing costs.

Looking forward, artificial intelligence-assisted image interpretation and procedural guidance are likely to further alter clinician workflows, improving lesion targeting and standardizing sampling strategies. As a result, stakeholders must adapt training curricula, refine credentialing frameworks, and reassess capital planning to align with a landscape that increasingly values precision, safety, and operational efficiency.

Supply chain resilience and procurement strategies reshaped by United States tariff adjustments, driving supplier diversification and regional manufacturing responses across device ecosystems

The cumulative impact of United States tariff adjustments in 2025 has reverberated across global medical device supply chains, compelling manufacturers and healthcare providers to reassess sourcing and procurement strategies for endobronchial ultrasound biopsy devices. Tariff-driven increases in component import costs have created upward pressure on manufacturing expenses, particularly for firms that rely on cross-border production of critical subassemblies and specialized ultrasound transducers. Firms responded by accelerating supplier diversification, shifting to regional vendors where feasible, and, in some cases, reprioritizing local manufacturing investments to mitigate future policy volatility.

On the clinical procurement side, acute awareness of tariff risk has prompted hospital systems and group purchasing organizations to negotiate longer-term supply contracts and to emphasize total cost of ownership in purchasing decisions. These negotiations increasingly consider consumable availability and aftermarket support as essential elements of device value. In parallel, manufacturers have sought to absorb some cost burdens through process improvements, lean manufacturing, and design choices that reduce reliance on tariff-impacted inputs.

Finally, regulatory and contracting teams have become more vigilant in modeling supplier continuity and in requiring transparent disclosure of sourcing footprints. For stakeholders, the tariff landscape underscores the importance of scenario planning, diversified supplier networks, and contract clauses that address cost pass-through to maintain predictable access to endobronchial ultrasound biopsy devices and related consumables.

In-depth segmentation perspective illuminating how product types, offerings, end users, applications, and clinical indications uniquely influence device selection and adoption

Segmentation analysis reveals distinct performance drivers and adoption pathways when the market is examined through product type, product offering, end user, application, and clinical indication lenses. By product type, the field differentiates devices that utilize linear probes, which afford direct visualization for guided needle aspiration of mediastinal and hilar nodes, and radial probes, which excel at peripheral lesion localization and enable complementary diagnostic strategies. When viewed by product offering, equipment investments-such as imaging workstations and scope systems-anchor capital planning and integration costs, while consumables, including needle sets and protective sheaths, shape recurrent spending and procedural throughput.

End-user contexts further nuance adoption dynamics: ambulatory surgical centers prioritize compact, efficient systems and streamlined consumables to support high-throughput outpatient procedures; hospitals emphasize advanced imaging capabilities, broad device interoperability, and comprehensive service agreements; and specialty clinics seek cost-effective configurations that balance diagnostic performance with space and staffing constraints. Applications span mediastinal staging, which demands high precision and reproducibility for staging decisions; peripheral lesion diagnosis, where lesion accessibility and imaging resolution are decisive; and transbronchial needle aspiration, which combines imaging and tissue acquisition and stresses needle design and sampling ergonomics.

Finally, clinical indications-ranging from cancer diagnostics to infectious disease evaluation and sarcoidosis assessment-influence both device selection and procedural protocols, as tissue adequacy, sample handling, and downstream molecular testing requirements vary substantially across these diagnostic pathways.

Regional adoption patterns and commercial imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific that shape deployment, training, and aftermarket strategies

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and commercial strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced tertiary care centers and robust interventional pulmonology programs supports early adoption of integrated imaging workstations and advanced scope systems, while payers increasingly scrutinize procedural pathways for cost-effectiveness and outcome alignment. Transitioning procedures to ambulatory surgical settings is creating new procurement priorities centered on mobility, ease of use, and consumable lifecycle management.

Within Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital funding models drive a mixture of centralized hospital deployments and targeted specialty clinic adoption. Manufacturers often tailor their market entry strategies to national reimbursement frameworks and to regional training partnerships with clinical societies. The Asia-Pacific region demonstrates accelerated uptake in urban tertiary centers and an expanding installed base driven by investments in cancer diagnostics infrastructure, with localized manufacturing and regional distribution partnerships playing pivotal roles in cost control and service responsiveness.

Across these regions, common themes emerge: emphasis on clinician training, the importance of service and warranty ecosystems, and the strategic role of consumables management in sustaining procedural volume. Decision-makers should therefore evaluate regional regulatory pathways, reimbursement nuances, and local clinical practice patterns when planning market entry or expansion.

Competitive landscape analysis highlighting divergent strategic models from integrated platform providers to consumable specialists and the implications for procurement and clinical adoption

Key companies within the endobronchial ultrasound biopsy ecosystem demonstrate a range of strategic approaches, from platform-integrated offerings to consumable-focused business models. Established endoscope manufacturers have leaned into system-level differentiation, combining high-resolution imaging workstations with modular scope architectures to capture procedural ecosystems and to drive consumable attachment. These firms emphasize long-term service contracts, clinician training programs, and bundled solutions that facilitate hospital integration and simplify procurement conversations.

Simultaneously, specialized manufacturers of needle systems and protective sheaths prioritize engineering focused on sampling reliability, tissue integrity, and single-use convenience. Their commercial strategies center on clinical evidence that demonstrates improved diagnostic yield and reduced repeat procedure rates, supported by targeted educational initiatives for interventional pulmonologists and cytopathology teams. Newer entrants and niche innovators often focus on adjunct technologies-such as navigation aids, biopsy forceps, or AI-enabled image enhancement-seeking strategic partnerships with platform holders to accelerate clinical adoption.

Overall, competitive dynamics are shaped by a balance between integrated platforms that lock in recurring consumable revenue and specialist suppliers that win on clinical performance and cost-efficient single-use designs. For purchasers, this dynamic increases the importance of evaluating total contractual arrangements, service level agreements, and the long-term roadmap for interoperability and software support.

Practical and high-impact strategic actions for manufacturers and healthcare providers to enhance clinical adoption, supply chain resilience, and long-term device value

Industry leaders seeking to strengthen market position and support sustainable clinical adoption should pursue a set of actionable strategies that align innovation with operational realities. First, prioritize end-to-end integration between scope systems and imaging workstations to deliver seamless clinical workflows and to reduce clinician friction at the point of care. Embedding robust training curricula and simulation-based credentialing will accelerate proficiency and minimize variability in biopsy technique, thereby improving sample quality and clinician confidence.

Second, develop resilient supply chains by diversifying component sourcing and by investing in regional manufacturing or assembly capabilities where feasible to mitigate trade and tariff exposure. Third, align commercial models with clinical workflows by offering flexible procurement options that address capital constraints, such as subscription-based access to imaging workstations combined with predictable consumable pricing. Fourth, invest in post-market evidence generation that demonstrates the impact of devices on diagnostic yield, downstream treatment decision-making, and patient experience, thereby supporting reimbursement discussions and hospital formulary inclusion.

Finally, foster interoperability and open data architectures to enable integration with electronic health records and multidisciplinary care platforms. These steps collectively will help firms and health systems navigate evolving clinical expectations, regulatory scrutiny, and fiscal pressures while expanding access to advanced endobronchial ultrasound biopsy capabilities.

Robust mixed-methods research approach integrating expert interviews, clinical literature review, and triangulated data analysis to validate insights and limit bias

The research methodology underpinning this analysis combined rigorous primary and secondary research techniques to ensure analytic depth and validity. Primary data collection included structured interviews with interventional pulmonologists, biomedical engineers, procurement leaders, and hospital administrators to capture real-world experiences with device performance, training needs, and consumable logistics. These expert inputs informed assessments of clinical workflows, device ergonomics, and procedural bottlenecks.

Secondary research encompassed a review of peer-reviewed clinical publications, device labeling and regulatory filings, clinical society guidelines, and publicly available regulatory communications to corroborate safety and efficacy claims and to map technology trends. Data triangulation ensured that insights reflected convergent evidence across sources, and sensitivity analyses were applied where qualitative inputs varied among experts. Segment definitions and regional analyses were constructed to align with clinical practice patterns, reimbursement frameworks, and supply chain geographies.

Limitations of the methodology include evolving regulatory landscapes and the pace of technological innovation, both of which can alter device capabilities and adoption dynamics. To address this, the research team applied conservative interpretation of nascent technologies and prioritized peer-reviewed evidence where available. Ethical considerations included anonymizing interview participants and securing consent for the use of proprietary insights in aggregate analysis.

Synthesis of strategic takeaways emphasizing technological progress, supply chain adaptation, and coordinated clinical strategies to maximize diagnostic outcomes

In conclusion, endobronchial ultrasound biopsy devices occupy a strategic position at the intersection of diagnostic precision, procedural safety, and operational efficiency. Technological innovations in probe design, imaging workstations, and single-use consumables are improving diagnostic performance while reshaping how procedures are delivered across ambulatory surgical centers, hospitals, and specialty clinics. At the same time, external pressures such as tariff-induced supply chain adjustments and evolving reimbursement practices are prompting manufacturers and providers to rethink sourcing, pricing, and commercialization models.

Successful deployment requires a holistic view that considers device interoperability, clinician training, consumable lifecycle management, and post-market evidence generation. By aligning product development with real-world clinical workflows and by establishing resilient supply chains, stakeholders can accelerate adoption while managing total cost of ownership and regulatory expectations. Ultimately, the balance between integrated platforms and high-performance consumables will determine how institutions structure purchasing decisions and how clinicians deliver consistent, high-quality diagnostic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endobronchial Ultrasound Biopsy Devices Market, by Product Type

  • 8.1. Linear Probe
  • 8.2. Radial Probe

9. Endobronchial Ultrasound Biopsy Devices Market, by Product Offering

  • 9.1. Consumables
    • 9.1.1. Needle Sets
    • 9.1.2. Protective Sheaths
  • 9.2. Equipment
    • 9.2.1. Imaging Workstations
    • 9.2.2. Scope Systems

10. Endobronchial Ultrasound Biopsy Devices Market, by Indication

  • 10.1. Cancer Diagnostics
  • 10.2. Infectious Diseases
  • 10.3. Sarcoidosis

11. Endobronchial Ultrasound Biopsy Devices Market, by Application

  • 11.1. Mediastinal Staging
  • 11.2. Peripheral Lesion Diagnosis
  • 11.3. Transbronchial Needle Aspiration

12. Endobronchial Ultrasound Biopsy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Endobronchial Ultrasound Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endobronchial Ultrasound Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endobronchial Ultrasound Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endobronchial Ultrasound Biopsy Devices Market

17. China Endobronchial Ultrasound Biopsy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACE Medical Devices Pvt. Ltd.
  • 18.6. Argon Medical Devices
  • 18.7. Boston Scientific Corporation
  • 18.8. Cook Group Incorporated
  • 18.9. EndoMed Systems GmbH
  • 18.10. FUJIFILM Corporation
  • 18.11. Huger Medical Instrument Co., Ltd.
  • 18.12. Hunan Vathin Medical Instrument Co., Ltd.
  • 18.13. Medi-Globe Technologies GmbH by DCC PLC
  • 18.14. Medtronic PLC
  • 18.15. Micro-Tech Endoscopy
  • 18.16. Olympus Corporation
  • 18.17. Siemens AG
  • 18.18. STERYLAB S.r.l
  • 18.19. TSK Laboratory International
  • 18.20. Zamar Care
  • 18.21. Zhuhai Pusen Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)